These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10914950)

  • 1. No response to cladribine in five patients with chronic cold agglutinin disease.
    Berentsen S; Tjønnfjord GE; Shammas FV; Bergheim J; Hammerstrøm J; Langholm R; Ulvestad E
    Eur J Haematol; 2000 Jul; 65(1):88-90. PubMed ID: 10914950
    [No Abstract]   [Full Text] [Related]  

  • 2. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of multiple sclerosis and other autoimmune diseases with cladribine.
    Beutler E; Sipe J; Romine J; McMillan R; Zyroff J; Koziol J
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):45-52. PubMed ID: 8714617
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia.
    Tetreault SA; Saven A
    Leuk Lymphoma; 2000 Mar; 37(1-2):125-30. PubMed ID: 10721776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An unusual effect of cyclosporine A in a patient with chronic lympholeukemia complicated by autoimmune hemolysis and thrombocytolysis].
    Vinogradova OA; Savchenko VG; Parovichnikova EN; Vakhrusheva TL; Ustinova EN
    Ter Arkh; 1998; 70(7):75-7. PubMed ID: 9742645
    [No Abstract]   [Full Text] [Related]  

  • 6. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
    Saven A
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunosuppressive treatments of patients with autoimmune disorders].
    Wasastjerna C
    Nord Med; 1967 Nov; 78(45):1469-75. PubMed ID: 6070858
    [No Abstract]   [Full Text] [Related]  

  • 8. [The immunosuppressive agents. 3. The immunosuppressive agents in hematology].
    Meshaka G; Jacquillat C; Sultan Y
    Presse Med (1893); 1967 Jul; 75(32):1653-5. PubMed ID: 6067478
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppressive long-term therapy of autoimmune diseases in hematology].
    Nelius D; Stieglitz R
    Z Gesamte Inn Med; 1972 Jun; 27(11):480-3. PubMed ID: 4626749
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of post-apheresis autoantibody rebound in cryoglobulinemia and cold agglutinin hemolytic anemia.
    L'Abbate A; Maggiore Q; Caccamo A; Bartolomeo F; Misefari V
    Int J Artif Organs; 1983 Jul; 6 Suppl 1():51-6. PubMed ID: 6642738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of autoimmune diseases].
    Moeschlin S
    Schweiz Med Wochenschr; 1971 Oct; 101(39):1393-9. PubMed ID: 4401236
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunosuppressive therapy].
    Melli G
    Recenti Prog Med; 1970 Jan; 48(1):1-18. PubMed ID: 4910156
    [No Abstract]   [Full Text] [Related]  

  • 13. [2-chlorodeoxyadenosine (2-CDA)--a new antineoplastic and immunosuppressive drug].
    Robak T; Grieb P
    Acta Haematol Pol; 1992; 23(3):141-8. PubMed ID: 1362851
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical use of immunosuppression.
    Watson DW; Johnson AG
    Med Clin North Am; 1969 Nov; 53(6):1225-41. PubMed ID: 4902918
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive treatment in immunopathologic disorders].
    Salmon J; Lambert PH
    J Belge Rhumatol Med Phys; 1967; 22(4):267-75. PubMed ID: 4390266
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug immunosuppression].
    Seipelt H
    Kinderarztl Prax; 1975 Jul; 43(7):308-25. PubMed ID: 51111
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunosuppressive agents or splenectomy in hematologic autoaggressive diseases? Clinical experiment report].
    Mey U
    Z Gesamte Inn Med; 1972 Mar; 27(6):250-4. PubMed ID: 5065518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunosuppressive treatment of autoimmune hemolytic anemias and chronic idiopathic thrombocytopenias].
    Wysocki K; Owczarek L; Wysocki H
    Pol Arch Med Wewn; 1974 Mar; 51(3):317-23. PubMed ID: 4822178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hematologic remission and disappearance of hemolytic anemia in chronic lymphocytic leukemia after therapy with 2-chlorodeoxyadenosine (2-CDA)].
    Piatkowska-Jakubas B; Skotnicki AB
    Acta Haematol Pol; 1993; 24(3):289-93. PubMed ID: 7902636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive therapy in management of non-malignant disease.
    Fennelly JJ; Fitzgerald MX; Fitzgerald O
    J Ir Med Assoc; 1970 Apr; 63(394):141-6. PubMed ID: 5418154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.